Developing a vaccine is a time-consuming and complex process, requiring a combination of specialized skills and technical capacities not readily available at a single organization.
TRANSVAC2 offers training courses to provide fundamental and advanced knowledge on a wide-range of vaccine development-related topics, centralising and expanding the training opportunities available to the European vaccine community.
Are you a researcher, a master or PhD student? Do you need to further develop your skills in order to advance your research and career?
On this call TRANSVAC2 offers two advanced courses on vaccine Process development and scale-up:
M9 Key considerations and best practices for viral vaccine process development, scale-up and implementation at manufacturing scale including single use technologies – offered by Vaccine Formulation Institute and Merck
M11 Process development and scale-up of recombinant protein vaccines - offered by Fraunhofer Institute for Molecular Biology and Applied Ecology IME
Submit your application at www.transvac.org/transvac2 by June 1st 2021.
